AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
NAPROXEN
50 registrations across 8 African markets— 38 active
Markets with NAPROXEN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| NAPROSYN EC TABLETS (Each tablets contains Naproxen 500mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| NAPROSYN EC TABLETS (Each tablets contains Naproxen 500mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| Naroxine Tablet_ Tablet | 🇳🇬Nigeria | Chez Resources Pharmaceutical Limited | active | Jun 2030 |
| Naproxen Tablet 500mg (Each tablet contains Naproxen 500mg) | 🇬🇭Ghana | — | active | Jun 2029 |
| Naproxen Tablet 500mg (Each tablet contains Naproxen 500mg) | 🇬🇭Ghana | — | active | Jun 2029 |
| NAPRIN Tablet | 🇰🇪Kenya | UNIJULES LIFE SCIENCES LTD B# 35 & 36, MIDC… | active | Apr 2028 |
| NAPROSCRIPT 500 TABLET; ORAL | 🇿🇼Zimbabwe | MULLER & PHIPPS | active | Dec 2027 |
| NAPROSCRIPT-250 TABLET; ORAL | 🇿🇼Zimbabwe | MULLER & PHIPPS | active | Dec 2027 |
| APO-NAPROXEN 250MG TABLET; ORAL | 🇿🇼Zimbabwe | APOTEX INC. | active | Dec 2027 |
| NAPROXEN 250MG TABLETS (Each gastro-resistant tablet contains Naproxen 250mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| NAPROXEN 500MG TABLETS (Each gastro-resistant tablet contains Naproxen 500mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| NAPROXEN 500MG TABLETS (Each gastro-resistant tablet contains Naproxen 500mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| NAPROXEN 250MG TABLETS (Each gastro-resistant tablet contains Naproxen 250mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| Cedax Tablet** Tablet | 🇳🇬Nigeria | Vixa Pharmaceutical Company Limited | active | Jun 2026 |
| Arthostop-500 Tablets** Tablet | 🇳🇬Nigeria | Maydon Pharmaceuticals Limited | active | Mar 2026 |
| Emzor Naproxen Tablet Tablet | 🇳🇬Nigeria | Emzor Pharmaceutical Industries Limited | active | Dec 2025 |
| STOPFLAM* | 🇿🇦South Africa | THE PREMIER PHARMACEUTICAL CO LTD | suspended | Sept 2025 |
| COMPU NAPROXEN | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| FIBROXYN 250 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| FIBROXYN 500 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| ADCO NAPROXEN 250 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2024 |
| MER-NAPROXEN DS* | 🇿🇦South Africa | THE PREMIER PHARMACEUTICAL CO LTD | suspended | Dec 2022 |
| MER-NAPROXEN* | 🇿🇦South Africa | THE PREMIER PHARMACEUTICAL CO LTD | suspended | Dec 2022 |
| PRANOXEN | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Dec 2022 |
| ADCO-NAPROXEN 500 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Dec 2022 |
| PROFLEX 500 | 🇿🇦South Africa | TRIOMED (PTY) LTD | suspended | Nov 2022 |
| PROFLEX 250 | 🇿🇦South Africa | TRIOMED (PTY) LTD | suspended | Nov 2022 |
| SANDOZ_NAPROXEN-250 250MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2016 |
| BIO-NAPROXEN 250 | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Jan 1900 |
| NAPFLAM 500 mg TABLETS | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| NAFASOL EC - 250 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| NAFASOL EC - 500 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| NAFASOL SUPPOSITORIES | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| NAPFLAM 250 mg TABLETS | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| NAPROSCRIPT 250 | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
| NAPGESIC | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| NAPROXEN 500 mg BLISS | 🇿🇦South Africa | Bliss Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| BE-TABS NAPROXEN 250* | 🇿🇦South Africa | SVIZERA SA (PTY) LTD | active | Jan 1900 |
| NAPROSCRIPT 500 | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
| NORITIS 250 | 🇿🇦South Africa | Unimed Healthcare (Pty) Ltd | active | Jan 1900 |
| *NAPROXEN 500 UNIMED | 🇿🇦South Africa | Unimed Healthcare (Pty) Ltd | active | Jan 1900 |
| NAPINAFLAM 250 mg | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Jan 1900 |
| NAPROXEN 250 OETHMAAN | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
| NAPROXEN 500 OETHMAAN | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
| NAPROXEN 250 mg BLISS | 🇿🇦South Africa | Bliss Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| Priaxen Tablets | 🇹🇿Tanzania | Remedica LTD | active | — |
| NAPROXEN ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | RAINBOW LIFE SCIENCES PVT.LTD. | active | — |
| NAPROXEN ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | RAINBOW LIFE SCIENCES PVT.LTD. | active | — |
| NAPROXEN ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | RAINBOW LIFE SCIENCES PVT.LTD. | active | — |
| NAPROXEN ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | RAINBOW LIFE SCIENCES PVT.LTD. | active | — |
NAPROXEN in Africa — Regulatory Overview
NAPROXEN is registered across 8 African markets with 50 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Uganda, Nigeria and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 50 registrations, 38 (76%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.